18 Fluid Therapy, Vasopressors, and Inotropes	149

Suggested Reading

1.De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–89.

The use of dopamine was associated with a greater number of adverse events. There were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine. A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock.

2.Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17–60.

Widely practiced guideline, a must read for all intensivists

3.Antonelli M, Levy M, Andrews PJF, et al. Hemodynamic monitoring in shock and implications for management International Consensus Conference, Paris, France; 2006 Apr 27–28. Intensive Care Med. 2007;33:575–90.

Consensus conference statements.

4.Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32(Suppl):S455–65.

A comprehensive literature review on the subject

Websites

1.www.survivingsepsis.org

Homepage of surviving sepsis campaign

2.www.slideshare.net

Powerpoint slide collection on the topic